Brief: Quince Therapeutics announces closing of up to $22 million private placement of securities
June 18 (Reuters) - Quince Therapeutics Inc QNCX.O: QUINCE THERAPEUTICS ANNOUNCES CLOSING OF UP TO $22 MILLION PRIVATE PLACEMENT OF SECURITIES Source text: ID:nBw6yb9L7a Further company coverage: QNCX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on IRulya Therapeutics
See all newsBrief: Quince Therapeutics - Changes Name To Irulya Therapeutics
Brief: Quince Therapeutics - Appoints Brigette Roberts As CEO Effective October 8, 2026
Quince Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Quince Therapeutics Reports Second Quarter 2026 Financial Results And Corporate Update
Quince Therapeutics Q2 net loss widens on acquisition charges